Researchers screened a panel of drugs that are already approved for clinical use and identified two drugs that provided effective SARS-CoV-2 suppression: cepharanthine and nelfinavir
Photo credit: Louis Reed on Unsplash
Preclinical experiments show that the drugs cepharanthine and nelfinavir may be effective treatments for COVID-19
While preventative care for COVID-19 has made much noise (with vaccines having rolled out in most countries), the soaring infection rates indicate the need for effective treatments. Using cultured cells to study SARS-CoV-2 infections, researchers at the Tokyo University of Science and other institutions have discovered that the drugs cepharanthine and nelfinavir are effective at combating the virus, with the former preventing the virus from entering cells and the latter preventing the virus from replicating.
COVID-19 continues to claim lives across the world and is infecting millions more. Although several vaccines have recently become available, making significant strides towards preventing COVID-19, what about the treatment of those who already have the infection? Vaccines aren’t 100% effective, highlighting the need — now more than ever — for effective antiviral therapeutics. Moreover, some people can’t receive vaccines due to health issues, and new variants of SARS-CoV-2, the virus that causes COVID-19, that can penetrate vaccine-conferred immunity, are being reported, indicating that we need to think beyond prevention.
Given this need, a team of researchers based in Japan, the US, and the UK launched a project to develop effective therapeutics. This team included several researchers based at Tokyo University of Science: Visiting Professor Koichi Watashi, Dr. Hirofumi Ohashi, Professor Shin Aoki, Professor Kouji Kuramochi, and Assistant Professor Tomohiro Tanaka. Their goal was clear and simple: finding a cure for COVID-19.
To achieve this goal, the researchers first established an experimental system for screening drugs that may help to control infections. This system used a type of cells called VeroE6/TMPRSS2 cells, which were manipulated to efficiently be infected with and produce SARS-CoV-2. “To determine whether a drug of interest could help combat infection by SARS-CoV-2, we simply had to expose VeroE6/TMPRSS2 cells to both the drug and SARS-CoV-2 and then observe whether the drug’s presence served to hinder the virus’s efforts to infect cells,” explains Professor Watashi.
The researchers used this experimental system to screen a panel of drugs that are already approved for clinical use, including drugs like remdesivir and chloroquine that have already being approved or are being trialed as treatments for COVID-19. In an exciting outcome, the researchers found two drugs that provided effective SARS-CoV-2 suppression: cepharanthine, which is used to treat inflammation, and nelfinavir, which is approved for the treatment of HIV infection.
Cepharanthine inhibited the entry of the virus into cells by preventing the virus from binding to a protein on the cell membrane, which it uses as a gateway. In contrast, nelfinavir worked to prevent the virus from replicating inside the cell by inhibiting a protein that the virus relies on for replication. Given that these drugs have distinct antiviral mechanisms, using both of them together could be especially effective for patients, with computational models predicting that combined cepharanthine/nelfinavir therapy can hasten the clearance of SARS-CoV-2 from a patient’s lungs by as few as 4.9 days.
So, does this mean we will be seeing these new drugs in COVID-19 treatment centers? Of course, the drug duo isn’t ready to be rolled out into healthcare systems just yet. These findings justify further research into the clinical potential of cepharanthine/nelfinavir therapy, and only following this can we say for sure that it is useful and helpful.
Nevertheless, given the ongoing nature of the COVID-19 pandemic and the ever-increasing death toll, the development of cepharanthine/nelfinavir therapy may provide clinicians and patients with a much-needed new treatment option.
Original Article: The Dream Team: Scientists Find Drug Duo That May Cure COVID-19 Together
More from: Tokyo University of Science
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Cepharanthine and nelfinavir
- PharmaDrug Advances Product and Clinical Development of Cepharanthine to Treat Infectious Diseases Including COVID-19on June 23, 2021 at 9:04 pm
Toronto, Ontario--(Newsfile Corp. - June 22, 2021) - PharmaDrug Inc. (CSE: BUZZ) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, ...
- The Globe and Mailon June 22, 2021 at 6:37 am
Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.
- PharmaDrug Advances Product and Clinical Development of Cepharanthine to Treat Infectious Diseases Including COVID-19on June 22, 2021 at 5:09 am
PharmaDrug Inc., a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics, cannabis and ...
- Monitoring T-Cell Exhaustion and Effects of Immunotherapyon June 7, 2021 at 12:20 pm
Many people pursue ideas of “efficiency” as an ideal for daily life — ideas include how many tasks we can accomplish in a short time frame and how we can minimize our impact on the environment. The ...
- COVID-19 Vaccine Booster Dose Controls Pandemicon June 4, 2021 at 4:56 pm
COVID-19 vaccines are of different types help to develop immunity to corona virus approximately two weeks after vaccination with a supply of memory B-lymphocytes as well as T-lymphocytes that will ...
Go deeper with Google Headlines on:
Cepharanthine and nelfinavir
Go deeper with Bing News on:
Treatments for COVID-19
- As Covid-19 warrior fights for his life, family starts crowdfunding for expensive treatmenton July 4, 2021 at 4:23 pm
As Covid-19 warrior fights for his life, family starts crowdfunding for expensive treatment Man who stole vehicles and sold them in Kashmir arrested It’s big, and it’s bold. AJIO has the most ...
- Can people vaccinated against COVID-19 still spread the coronavirus?on July 4, 2021 at 2:18 pm
The COVID-19 vaccines are a smash success. But that doesn't mean they keep every vaccinated person completely free of the coronavirus.
- New $1.7 million project to identify potential COVID-19 treatmentson July 2, 2021 at 7:24 am
CSIRO, Australia's national science agency, will spearhead a $1.7 million project to identify new treatments for COVID-19, including 'long-COVID'.
- Matt Taibbi: Reporting on potential COVID-19 treatments like ivermectin shouldn't be taken as an endorsementon July 1, 2021 at 12:03 pm
Reporter Matt Taibbi on Thursday argued that journalists should be permitted to write about certain topics without being painted as a supporter of what they report on after receiving backlash for writ ...
- Uganda Approves Herbal Treatment for COVID-19on June 30, 2021 at 12:54 pm
The World Health Organization has expressed concern about Uganda's approval of a locally made herbal treatment for COVID-19 amid a third wave of cases. The WHO has not approved the substance for ...